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Background: Environmental factors that inﬂuence wheezing in early childhood in the developing world
are not well understood and may be useful in predicting respiratory outcomes. Therefore, our objective
was to determine the factors that can predict wheezing.
Methods: Children from Dhaka, Bangladesh were recruited at birth and episodes of wheezing were
measured alongside nutritional, immunological and socioeconomic factors over a one-year period.
Poisson Regression with variable selection was utilized to determine what factors were associated with
wheezing.
Results: Elevated serum IL-10 (rate ratio (RR) ¼ 1.51, 95% conﬁdence interval (CI): 1.22e1.87), IL-1b
(RR ¼ 1.55, 95% CI: 1.26e1.93) C-reactive protein (CRP) (RR ¼ 1.41, 95% CI: 1.03e1.93) in early life, and
male gender (RR ¼ 1.52, 95% CI: 1.27e1.82) predicted increased wheezing episodes. Conversely, increased
fecal alpha-1-antitrypsin (RR ¼ 0.87, 95% CI: 0.76e1.00) and family income (RR ¼ 0.98, 95% CI: 0.97
e0.99) were associated with a decreased number of episodes of wheezing.
Conclusions: Systemic inﬂammation early in life, poverty, and male sex placed infants at risk of more
episodes of wheezing during their ﬁrst year of life. These results support the hypothesis that there is a
link between inﬂammation in infancy and the development of respiratory illness later in life and provide
speciﬁc biomarkers that can predict wheezing in a low-income country.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Wheezing in early life in low income countries often occurs with
acute lower respiratory infections, which are a leading cause of
morbidity and mortality in children under ﬁve years of age [1,2].
Early childhood wheezing also increases the risk of later develop-
ment of asthma, which in addition to increasing morbidity, places
signiﬁcant socioeconomic burden on already distressed pop-
ulations [3,4]. Early life markers that predict the development of
wheezing in infants in low-income populations are not well un-
derstood and could be useful in allowing early interventions and in
understanding the pathogenesis of respiratory diseases. SystemicLtd. This is an open access article uinﬂammation might provide such a marker. In high income coun-
tries autoimmune and inﬂammatory diseases often predispose to
or co-occur with wheezing and asthma, howevermost studies have
focused on adult populations [5e7]. Recent studies and a more
nuanced understanding of the hygiene hypothesis, the idea that
early life infections might help prevent the development of al-
lergies and asthma, and in turn wheezing, has suggested that in-
fections with some pathogenic organisms are in fact detrimental to
later respiratory health [8e11]. Clinical and subclinical infection
with enteric and non-enteric organisms is very common in children
in low income countries and likely represents an environmental
factor that contributes to a persistent inﬂammatory response in
those children [12,13].
Pathogens encountered by children in these communities can
signiﬁcantly elevate serum levels of pro-inﬂammatory cytokines
such as IL-1b and macrophage inﬂammatory protein (MIP1b) alongnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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countries these cytokines have also been shown to be associated
with obstructive respiratory diseases and wheezing [16,17]. In
addition to inﬂammation stimulated by respiratory pathogens and
exposures, children in developing country settings may have
additional exposures leading to inﬂammation, especially in settings
of poor sanitation and repeated exposure to enteric pathogens.
Indeed, environmental enteropathy, an inﬂammatory condition of
the intestine that can occur in individuals without evidence of overt
diarrhea and disease, is also very common in children in low in-
come countries and is thought primarily to be the result of poor
sanitation and repeated infection with enteropathogens
[12,13,18e20]. Environmental enteropathy is deﬁned pathologically
by inﬂammatory cell inﬁltration and villous blunting in the mucosa
of the small intestine and is associated with gut barrier dysfunction
and intestinal and systemic inﬂammation, including elevated
serum IL-1b, and elevated C-reactive protein at multiple time
points [13,19,21]. Markers of gut barrier dysfunction include, but
are not limited to, a 1 antitrypsin (ATT). AAT in stool is commonly
utilized as a marker of protein-losing enteropathy in children [22].
Thus, considering the potential impact of systemic inﬂammation
on respiratory outcomes, we postulated that markers associated
with environmental enteropathy, including serum inﬂammatory
cytokines in the ﬁrst weeks of life, might predict wheezing out-
comes over the ﬁrst year of life in children in Mirpur, Dhaka
Bangladesh. To test this idea an exploratory analysis of the ability of
early inﬂammation to predict wheezing was conducted in an in-
dependent cohort from the same community. 37.5% of children in
this exploratory cohort had at least one instance of wheezing.
Elevated serum IL-10 (top 25th percentile) at 6 months of life was
signiﬁcantly associated with increased episodes of wheezing by
one year of age (rate ratio (RR) ¼ 1.48, 95% conﬁdence interval (CI)
1.19e1.77). This preliminary data suggested that systemically
elevated serum cytokines early in life might predict wheezing.
2. Methods
2.1. Hypothesis generation cohort
A preliminary investigation of the association of serum cytokine
levels with number of nebulizer treatments was performed in a
small subset of children (147) from an earlier birth cohort study
from the Mirpur area of Bangladesh. These 147 infants were
enrolled after birth, beginning in January 2008, and followed until
one year of age. The study period ended September 2009. Full de-
tails of the design of this birth cohort study have been described
[23]. The results from this subset of 147 infants showing signiﬁcant
association of cytokine measures led us to the detailed investiga-
tion of biomarker effects on wheezing outcomes in the “ Perfor-
mance of Rotavirus and Oral Polio Vaccines in Developing
Countries” (PROVIDE) study cohort of 700 infants.
2.2. Study design and subjects
The characteristics of the PROVIDE study population and study
design have been previously described [20,24]. Brieﬂy, a birth
cohort of 700 children from the Mirpur urban slum in Dhaka,
Bangladesh were recruited and followed for 2 years. The objectives
of the study were to determine the effect of environmental enter-
opathy and inﬂammation on oral vaccine performance and infant
health. Our objective was to evaluate respiratory outcomes in the
ﬁrst year of life in this cohort. In the ﬁrst year of life, 626 children
remained in the study by month 6 and 609 by month 12 of follow-
up. There were 4 deaths during the entire PROVIDE study which
occurred before one year of age and were due to respiratorydistress, acute diarrhea, neonatal sepsis, and cardio-respiratory
failure. All studies were approved by the Ethical Review Commit-
tee of the ICDDR, B and the Institutional Review Boards of the
Universities of Virginia and Vermont. Informed consent was ob-
tained for all participating mothers and infants, including permis-
sion for repeated blood draws.
2.3. Measurement of wheezing
Episodes of wheezing requiring clinician-administered nebu-
lizer treatment were counted over the ﬁrst year of life for each child
in the study. Wheezing was assessed by the clinic physician as a
continuous whistling or course airway sound during inspiration
and/or exhalation [25]. An episode of wheezing was formally
deﬁned for this study as at least one nebulizer treatment (salbu-
tamol, 0.1 mg per kilogram body weight) within a 10 day period
[26]. In this study, our clinic served as the primary care clinic for the
enrolled children and access to other healthcare was extremely
limited, including home use of nebulizers.
2.4. Baseline characteristics and biomarkers
Baseline characteristics in this study included monthly family
income, expenditure and maternal education. Biomarkers utilized
in this analysis and the number of children available for each
marker in both univariate and multivariate analyses are indicated
in Table S1, along with clinical reference values when available.
Mean ± Standard Error (S.E.) for continuous biomarkers and per-
centage for categorical measures is also provided in Table S1. Only
biomarkers measured at 6, 12, and 18 or 24 weeks were included in
the univariate and multivariate analyses, and those children with
missing biomarker measurements were excluded from the indi-
vidual analysis. Cytokine biomarkers of systemic inﬂammation
were categorized into the bottom 50th percentile, 50th75th, and
75th and above, with the reference the bottom 50th.
2.5. Measure of sustained inﬂammation
C- reactive protein (CRP) was measured at weeks 6, 18 and 40. A
CRP value was considered to be elevated if it was above the median
value of CRPs at each time. Children were classiﬁed into four
groups: Group 0 consisted of those in which none of their CRPs
were elevated, Group 1 if one CRPmeasurewas elevated, Group 2 if
two CRPs were elevated and Group 3 if all three CRPs were
elevated. Group 0 was considered as the reference in this analysis.
Sustained inﬂammation with respect to CRPs was deﬁned as if at
least two CRP measures were elevated.
2.6. Statistical analysis
Univariate Poisson regression was performed to evaluate the
association of biomarkers from the PROVIDE study with episodes of
wheezing. Based on univariate p values, the false discovery rate
(FDR) was calculated to correct for multiple comparisons and those
biomarkers with a FDR < 20% were considered as informative or
important. The objective of the univariate analysis with FDR
correction was to identify signiﬁcant biomarkers individually that
predicted episodes of wheezing over a one year period. While
univariate analysis indicates the marginal effect of individual bio-
markers, multivariable analysis can show joint effects of bio-
markers. However, since there are nearly 50 predictors (Table S1) in
this analysis, a situation of high-dimensional data, traditional
multivariable analysis was not an optimal approach. Thus, a mod-
ern variable selection method with smoothly clipped absolute de-
viation (SCAD) regularization was utilized to identify a subset of
Table 1
Predictors of wheezing by one year of age (univariate Poisson regression).
Predictor/Biomarkers Rate ratio 95% CI, L 95% CI, H FDR
Male gender 1.52 1.27 1.82 <0.01
Retinol binding protein at week 6 0.98 0.97 0.99 <0.01
Retinol binding protein at week 18 0.99 0.98 1.00 0.01
C reactive protein at week 18 1.01 1.00 1.02 0.14
alpha 1 antitrypsin at week 12 0.87 0.76 1.00 0.14
expenditure 0.98 0.97 0.99 0.03
income 0.98 0.97 0.99 0.01
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outcome. The ﬁnal model was determined using the Bayesian in-
formation criterion (BIC) and based on the biological plausibility.
Results were conﬁrmed with stepwise Poisson regression, not
shown. In addition, univariate Poisson regressionwas performed to
evaluate an association between sustained inﬂammation, as
measured by number of elevated CRP tests, and wheezing. All
statistical analyses were performed using SAS 9.3 (SAS Institute;
Cary, NC) and the “grpreg” package in R 3.1 (www.r-project.org).IL-1 b week 18_2* 1.43 1.15 1.78 0.01
IL-1 b week 18_3 1.55 1.26 1.93 <0.01
IL-10 week 18_2 1.27 1.02 1.59 0.12
IL-10 week 18_3 1.51 1.22 1.87 <0.01
Mip1b week 18_3 1.26 1.02 1.56 0.12
IL-7 week 18_2 1.37 1.07 1.75 0.05
IL-7 week 18_3 1.27 0.98 1.63 0.17
*Cytokine biomarkers were categorized as bottom 50th percentile, 50th75th (2)
and above 75th (3).
Table 2
Predictors of wheezing (SCAD multivariable selection).
Predictors/Biomarkers Rate ratio
Male gender 1.46
Retinol binding protein at week 6 (mg/ml) 0.997
Retinol binding protein at week 18 (mg/ml) 0.999
Alpha-1-antitrypsin at week 12 (mg/g) 0.93
Income (1000 Taka) 0.98
IL-1 b at week 18, 50e75th percentile 1.07
IL-1 b at week 18, above 75th percentile 1.11
IL-10 at week 18, 50e75th percentile 1.03
IL-10 at week 18, above 75th percentile 1.063. Results
In the PROVIDE cohort 43.3% of children had at least one episode
of wheezing over the ﬁrst year of life (Fig. 1). Univariate analysis
(Table 1, S1) showed that increased risk of wheezing was associated
with male gender (RR:1.52, 95% CI: 1.27e1.82), CRP (RR: 1.01, 95%
CI: 1.00, 1.02), IL-10 (RR: 1.51, 95% CI: 1.22e1.86), IL-1b (RR: 1.55,
95% CI: 1.25e1.92), Mip1b (RR: 1.26, 95% CI: 1.02e1.56) and IL-7
(RR: 1.27, 95% CI: 0.98e1.63). Increased family income (RR: 0.98,
95% CI: 0.96e0.99), retinol binding protein, at 6 and 18weeks of age
(RR: 0.98, 95% CI: 0.97e0.99, and RR: 0.98. 95% CI: 0.98e0.99) and
fecal alpha-1-antitrypsin at 12 weeks of age (RR: 0.87, 95% CI:
0.76e1.00) were associated with decreased episodes of wheezing.
Multivariable analysis demonstrated that male gender, IL-10, IL-
1b, family income, retinol binding protein, and fecal alpha-1-
antitrypsin were signiﬁcant independent predictors of wheezing
(Table 2, S1). Sustained inﬂammation, as deﬁned by elevated CRP
levels at two or three time points (CRP group 2, 3) was also posi-
tively and signiﬁcantly associated with the number of episodes of
wheezing in the ﬁrst year of life (Table 3).Table 3
Association of sustained inﬂammation with future wheezing.
CRP group No. of children (%) Rate ratio 95% CI, L 95% CI, H P Value
CRP group 0* 102 (17.9) 1.0 (ref.)
CRP group 1 178 (31.2) 1.09 0.81 1.46 0.59
CRP group 2 186 (32.6) 1.49 1.12 1.97 0.01
CRP group 3 104 (18.3) 1.41 1.03 1.93 0.03
*CRP was measured at weeks 6, 18 and 40, and deﬁned as elevated if the measure
was above the median for each week. Group 0: non CRP measures were elevated,
Group 1: 1 CRP measure elevated, group 2: 2 CRPs were elevated, group 3: all three
CRPs were elevated.4. Discussion
The most important discovery of this work was the association
of early life inﬂammation with increased risk of wheezing in the
ﬁrst year of life. This was found in two independent birth cohorts of
slum dwelling infants in urban Bangladesh. Wheezing was com-
mon in both of these cohorts as expected, with 37.5% and 43.3% of
children having at least one episode over a 1-year period [27].
Earlier work is supportive of a link of inﬂammation with wheezing.
Increased IL-10 production from monocytes was predictive of a
recurrence of wheezing in children from the Netherlands [17].
Children from Rotterdamwho developed wheezing in the ﬁrst year
of life had an increased IL-10/IL-12 ratio [28]. Finally, pro-
inﬂammatory cytokines were observed in bronchoalveolar lavage
ﬂuid from infants in Finland with frequent wheeze [29]. The PRO-
VIDE study however represents the most comprehensive survey of
inﬂammatory markers and environmental factors associated withFig. 1. Number of episodes of wheezing requiring nebulizer treatment in the ﬁrst year
of life in the PROVIDE cohort.risk of wheezing in infants in a tropical urban slum. It is unique in
showing that systemic inﬂammation, as measured by increased
levels of serum IL-1b and IL-10 and sustained C reactive protein
(CRP), is predictive of an increased risk of wheezing in this
population.
IL-1b is a pro-inﬂammatory cytokine that is signiﬁcantly
elevated during both enteric and respiratory infections while IL-10
is an anti-inﬂammatory cytokine that is often induced in response
to pro-inﬂammatory cytokines such as IL-1b [15,30]. It was there-
fore anticipated that elevation in both of these cytokines would be
observed in inﬂammatory states and would predict episodes of
wheezing, as shown by our analysis. AAT in stool is commonly
utilized as a marker of protein-losing enteropathy in children [22].
AAT was not clinically elevated in this cohort of children. However,
it was expected that AAT would serve as a marker of increased
inﬂammation and intestinal damage in this analysis, and that
higher levels might be expected to predict increased wheezing,
rather than decreased. Future studies will examine the implications
of this unexpected ﬁnding.
Additional serum inﬂammatory markers predicted wheezing in
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associated with T cell and macrophage activation, and Mip1b,
associated with macrophage and neutrophil activation. Further
supporting an association of inﬂammation and wheezing was the
observation that an increased number of time points with elevated
CRP predicted increased episodes of wheezing. This result suggests
that sustained inﬂammation, known to occur in environmental
enteropathy, is also an important marker of the development of
wheezing [19].
Our univariate analysis selected serum retinol binding protein as
a predictor of decreased episodes of wheezing. Our multivariable
analysis also indicated that serum retinol binding protein could
predict episodes of wheezing, but does not permit a strong state-
ment of directionality. Retinol binding protein is a negative acute
phase protein, and levels of it signiﬁcantly decrease during infec-
tion and sepsis [31]. However, retinol binding protein levels also
closely correlate with levels of dietary vitamin A, and can be uti-
lized as a marker of vitamin A deﬁciency even during infection and
protein malnutrition [32]. Children with vitamin A deﬁciency have
previously been shown to be more likely to wheeze during acute
respiratory infections [33]. Future studies will examine the etiology
of the association between increased serum cytokines and level of
retinol binding protein and wheezing to determine if enter-
opathogen burden or dietary vitamin A intake associate with serum
retinol levels and wheezing in these children.
Low family income has in other studies also been associated
with increased episodes of wheezing in the 1st year of life, as has
male gender [34,35]. In this study, these were independent of
inﬂammation in multivariable analysis, suggesting that their po-
tential to promote wheezing is through some mechanism other
than inﬂammation. Maternal factors, including education, height
and weight, were evaluated as potential factors inﬂuencing
wheezing as previous studies have suggested that maternal health
and education might inﬂuence childhood respiratory health [36].
However, we found no association between these factors and
wheezing. Future studies will examine maternal factors and their
inﬂuence on wheezing in more depth.
The strengths of our study included a large number of children
in an isolated cohort and the collection of a large amount of data on
subjects with repeated serum and fecal samples. Thus health care
data could be utilized and a comprehensive set of biomarkers were
able to be developed and evaluated. Nevertheless, this study had
some limitations. The cause of the wheezing episodes was not
measured, however, the young age of the population and the lack of
association of serum IL-4 and IL-5 with wheezing, make a viral and
not atopic origin of wheezing more likely. Another limitation was
the high baseline level of inﬂammation in the population as a
whole which may have masked the full contribution of inﬂamma-
torymarkers and their role in exacerbating wheezing episodes [18].
Finally, the two cohorts reported here were observational and
cannot address causality but merely note the association between
biomarkers of inﬂammation and wheezing. In future work it will be
important to address the cause of early inﬂammation, which we
hypothesize to be due to a combination of enteric and respiratory
infections, so that directed interventions can be tested for their
impact on mitigation of wheezing in infant and later childhood
populations.
In summary, we have shown that systemic inﬂammation was
associated with an increased risk of wheezing in the 1st year of life
in slum dwelling children from Bangladesh. This study demon-
strated that IL-1b, IL-10, alpha-1-antitrypsin and C-reactive protein
were important biomarkers in early life, predicting the later
development of wheezing. The greater signiﬁcance of this work lies
in the demonstration that systemic inﬂammation may predispose
to more severe respiratory outcomes later in life.Acknowledgments
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